Capsule formulations to improve delivery of poorly absorbable drugs

Biotechs have limited funding, and their investors must regularly be shown constant tangible project progress in the Drug Discovery phase. Biotechs whose projects lag, have their funding and future at risk. Likewise, large pharma must continually re-prioritize its portfolio of Discovery projects, and those that progress fastest typically have the best chance for survival. One irony of the entire drug discovery process is that despite the introduction of (or maybe because of) new “enabling” technologies across biology, chemistry, and computational sciences the average cycletimes of drug discovery projects from target identification to candidate selection has remained relatively static over the years, rather than becoming shorter. Yet some Discovery projects progress faster than others, and a number of factors for reducing cycletime are well within the control of the project investigators. What are these strategies?

This webinar will discuss the technology of hair testing and present on the situation in Brazil. There is consequently, a very large numbers of hair tests taking place, and laboratories must meet the need for high throughput and sensitivity.

Pharmaceutical companies and their drugs face numerous challenges in the brief window between launch and patent expiration. This makes it extremely important to plan lifecycle management (LCM) strategies well in advance of patent expiry. One way to address this is with advanced manufacturing techniques that make it much more difficult for competitors to genericize. For pharmaceutical companies that seek market enhancement strategies beyond the capabilities of existing fast melt technologies, join Contract Pharma for this webinar as we hear from Don Wetherhold, the senior executive advisor and senior vice president of Aprecia Pharmaceuticals. He will talk about the company’s innovative ZipDose technology and why it offers an exclusive opportunity to address patient demand and create products not easily genericized.

Individualized, precision medicine is an evolving medical model and is key in helping clinicians reach accurate diagnoses and effective treatment plans for many patients. There are much promise and hype around precision medicine, but implementing and scaling a precision medicine program is challenging. Multiple disciplines must collaborate in order to reach an accurate diagnosis and effective treatment plans. Unfortunately, information is frequently in sales, disparate systems, or lost.